These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36477906)

  • 1. [Anesthesiological and postinterventional management in percutaneous hepatic melphalan perfusion (chemosaturation)].
    Kliem P; Ebel S; Werdehausen R; Girrbach F; Bösemann D; van Bömmel F; Denecke T; Stehr S; Struck MF
    Anaesthesiologie; 2023 Feb; 72(2):113-120. PubMed ID: 36477906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemosaturation with percutaneous hepatic perfusions of melphalan for hepatic metastases: experience from two European centers.
    Vogl TJ; Zangos S; Scholtz JE; Schmitt F; Paetzold S; Trojan J; Orsi F; Lotz G; Ferrucci P
    Rofo; 2014 Oct; 186(10):937-44. PubMed ID: 24729409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombotic occlusion of the extracorporeal circulation during hepatic chemosaturation despite targeted anticoagulation : A case report].
    Kuhner M; Tan B; Fiedler MO; Biecker O; Klein B; Chang DH; Weigand MA; Dietrich M
    Anaesthesiologie; 2022 Nov; 71(11):852-857. PubMed ID: 35925192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience.
    Artzner C; Mossakowski O; Hefferman G; Grosse U; Hoffmann R; Forschner A; Eigentler T; Syha R; Grözinger G
    Cancer Imaging; 2019 May; 19(1):31. PubMed ID: 31146793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review.
    Vogel A; Gupta S; Zeile M; von Haken R; Brüning R; Lotz G; Vahrmeijer A; Vogl T; Wacker F
    Adv Ther; 2017 Jan; 33(12):2122-2138. PubMed ID: 27798773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemosaturation Percutaneous Hepatic Perfusion (CS-PHP) with Melphalan: Evaluation of 2D-Perfusion Angiography (2D-PA) for Leakage Detection of the Venous Double-Balloon Catheter.
    Dewald CLA; Meine TC; Winther HMB; Kloeckner R; Maschke SK; Kirstein MM; Vogel A; Wacker FK; Meyer BC; Renne J; Hinrichs JB
    Cardiovasc Intervent Radiol; 2019 Oct; 42(10):1441-1448. PubMed ID: 31089781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of melphalan, oxaliplatin, and paclitaxel in colon, liver, and gastric cancer cell lines in a short-term exposure model of chemosaturation therapy by percutaneous hepatic perfusion.
    Uzgare RP; Sheets TP; Johnston DS
    Anticancer Res; 2013 May; 33(5):1989-2000. PubMed ID: 23645748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous isolated hepatic perfusion (chemosaturation) with melphalan following right hemihepatectomy in patients with cholangiocarcinoma and metastatic uveal melanoma: peri- and post-interventional adverse events and therapy response compared to a matched group without prior liver surgery.
    Dewald CLA; Becker LS; Maschke SK; Meine TC; Alten TA; Kirstein MM; Vogel A; Wacker FK; Meyer BC; Hinrichs JB
    Clin Exp Metastasis; 2020 Dec; 37(6):683-692. PubMed ID: 33034815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies.
    Libutti SK; Barlett DL; Fraker DL; Alexander HR
    J Am Coll Surg; 2000 Nov; 191(5):519-30. PubMed ID: 11085732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy by isolated liver perfusion with endovascular occlusion catheter: preliminary experience in pigs].
    Savier E; Lokiec F; Le Fur S
    Ann Chir; 2000 Jun; 125(5):462-7. PubMed ID: 10925489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival.
    Marquardt S; Kirstein MM; Brüning R; Zeile M; Ferrucci PF; Prevoo W; Radeleff B; Trillaud H; Tselikas L; Vicente E; Wiggermann P; Manns MP; Vogel A; Wacker FK
    Eur Radiol; 2019 Apr; 29(4):1882-1892. PubMed ID: 30255257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous hepatic melphalan perfusion: Single center experience of procedural characteristics, hemodynamic response, complications, and postoperative recovery.
    Struck MF; Kliem P; Ebel S; Bauer A; Gössmann H; Veelken R; van Bömmel F; Dennecke T; Stehr SN; Girrbach FF
    PLoS One; 2021; 16(7):e0254817. PubMed ID: 34270628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosaturation of the Liver - an Update.
    Ebel S; Struck MF; van Boemmel F; Beeskow AB; Gößmann H; Denecke T
    Rofo; 2023 Jan; 195(1):30-37. PubMed ID: 35977553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan.
    Lindnér P; Fjälling M; Hafström L; Kierulff-Nielsen H; Mattsson J; Scherstén T; Rizell M; Naredi P
    Eur J Surg Oncol; 1999 Apr; 25(2):179-85. PubMed ID: 10218462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemosaturation for primary and secondary liver malignancies: A comprehensive update of current evidence.
    Vogel A; Ochsenreither S; Zager JS; Wacker F; Saborowski A
    Cancer Treat Rev; 2023 Feb; 113():102501. PubMed ID: 36587472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosaturation with Percutaneous Hepatic Perfusion: Outcome and Safety in Patients with Metastasized Uveal Melanoma.
    Dewald CLA; Hinrichs JB; Becker LS; Maschke S; Meine TC; Saborowski A; Schönfeld LJ; Vogel A; Kirstein MM; Wacker FK
    Rofo; 2021 Aug; 193(8):928-936. PubMed ID: 33535258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Factors for Postoperative Bleeding Complications and Prolonged Intensive Care after Percutaneous Hepatic Chemosaturation Procedures with Melphalan.
    Struck MF; Werdehausen R; Kirsten H; Gössmann H; Veelken R; van Bömmel F; Stehr S; Denecke T; Ebel S
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases.
    Carr MJ; Sun J; Cohen JB; Liu J; Serdiuk AA; Stewart SR; Doobay N; Duclos A; Seal DA; Choi J; Zager JS
    Cancer Control; 2020; 27(1):1073274820983019. PubMed ID: 33372814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous hepatic perfusion in patients with metastatic liver cancer: anesthetic, hemodynamic, and metabolic considerations.
    Miao N; Pingpank JF; Alexander HR; Steinberg SM; Beresneva T; Quezado ZM
    Ann Surg Oncol; 2008 Mar; 15(3):815-23. PubMed ID: 18180999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.
    Ben-Shabat I; Hansson C; Sternby Eilard M; Cahlin C; Rizell M; Lindnér P; Mattsson J; Olofsson Bagge R
    J Vis Exp; 2015 Jan; (95):52490. PubMed ID: 25650893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.